Home

Find out the latest news from international oncology congresses and stay at the forefront of clinical innovation and advances in lung cancer research. Each SPECIAL ISSUE – CONGRESS REPORT features informative summaries of key topics from lung cancer to come out of a major international oncology congress.

The memo inOncology Medical education series: keeping oncologists at the forefront of lung cancer research. memo – inOncology Special Issue Preceptorship reports summarise the latest in lung cancer research and treatments to come out of our sponsored Preceptorship meeting series. The Fundamentals of Designing Clinical Trials series arms oncologists with the information they need to plan and conduct an oncology trial.

 

Sanjay Popat talks about modern chemotherapeutic treatment options for patients with squamous NSCLC, the benefits of combining immunotherapies with chemotherapy and the use of liquid biopsy for metastatic NSCLC in clinical practice today

Preceptorship Singapore

Basics of leadership in clinical research with a focus on lung cancer

Young Oncologist Preceptorship, 8th–10th December, 2017, Singapore

memo – inOncology SPECIAL ISSUE
ESMO Congress report 2018
The latest findings in lung cancer to come out of the ESMO Congress held from 19th to 23rd October in Munich!

Download Report!

News

Springer is delighted to announce a new memo inOncology SPECIAL ISSUE congress report from this years ESMO!

Congress Report ESMO 2018
memo – inOncology SPECIAL ISSUE
Congress Report ESMO 2018 
This report includes the latest advancements of checkpoint inhibitors, which excel in all treatment lines of lung cancer therapies, as well as novel potent treatment options for ALK– and MET– positive disease. Additionally, this report focuses on what is new with respect to activity and resistance of EGFR TKIs in EGFR-mutant lung cancer.

 

 


Springer memo Preceptorship Cologne CoverPreceptorship Shanghai – Modern Management of Advanced Lung Cancer:
Immunotherapy & Targeted Agents
Springer and the Shanghai Pulmonary Hospital held the Lung Cancer International Preceptorship on the 28th-29th June 2018, in Shanghai, China. The overall topic was the modern management of advanced lung cancer: Immunotherapy & Targeted Agents

Access the report here


Expert interviews at ESMO 2018

 

Dr. Sanjay Popat talks about modern chemotherapeutic treatment options for patients with squamous NSCLC, the benefits of combining immunotherapies with chemotherapy and the use of liquid biopsy for metastatic NSCLC in clinical practice today.

Dr. Luis Paz-Ares explains new principles of treatment using bifunctional fusion proteins, their advantages compared to the existing therapies and preliminary results in NSCLC patients.